Authors:
Burkhardt, K
Radespiel-Troger, M
Rupprecht, HD
Goppelt-Struebe, M
Riess, R
Renders, L
Hauser, IA
Kunzendorf, U
Citation: K. Burkhardt et al., An increase in myeloid-related protein serum levels precedes acute renal allograft rejection, J AM S NEPH, 12(9), 2001, pp. 1947-1957
Authors:
Renders, L
Mayer-Kadner, I
Koch, C
Scharffe, S
Burkhardt, K
Veelken, R
Schmieder, RE
Hauser, IA
Citation: L. Renders et al., Efficacy and drug interactions of the new HMG-CoA reductase inhibitors cerivastatin and atorvastatin in CsA-treated renal transplant recipients, NEPH DIAL T, 16(1), 2001, pp. 141-146
Authors:
Fischereder, M
Luckow, B
Hocher, B
Wuthrich, RP
Rothenpieler, U
Schneeberger, H
Panzer, U
Stahl, RAK
Hauser, IA
Budde, K
Neumayer, HH
Kramer, BK
Land, W
Schlondorff, D
Citation: M. Fischereder et al., CC chemokine receptor 5 and renal-transplant survival, LANCET, 357(9270), 2001, pp. 1758-1761
Authors:
Koziolek, MJ
Riess, R
Geiger, H
Thevenod, F
Hauser, IA
Citation: Mj. Koziolek et al., Expression of multidrug resistance P-glycoprotein in kidney allografts from cyclosporine A-treated patients, KIDNEY INT, 60(1), 2001, pp. 156-166
Authors:
Wassmuth, R
Hauser, IA
Schuler, K
Erxleben, H
Arnold, ML
Koelman, CA
Claas, FHJ
Kalden, JR
Citation: R. Wassmuth et al., Differential inhibitory effects of intravenous immunoglobulin preparationson HLA-alloantibodies in vitro, TRANSPLANT, 71(10), 2001, pp. 1436-1442
Citation: Ia. Hauser, Hans U. Zollinger Award 2000: Problems from the clinic, answers from the laboratory: Mutual interactions that lead to rationales for an optimized andindividualized immunosuppressive regimen, KIDNEY BL P, 23(3-5), 2000, pp. 154-155
Authors:
Baer, PC
Gauer, S
Hauser, IA
Scherberich, JE
Geiger, H
Citation: Pc. Baer et al., Effects of mycophenolic acid on human renal proximal and distal tubular cells in vitro, NEPH DIAL T, 15(2), 2000, pp. 184-190
Authors:
Thevenod, F
Friedmann, JM
Katsen, AD
Hauser, IA
Citation: F. Thevenod et al., Up-regulation of multidrug resistance P-glycoprotein via nuclear factor-kappa B activation protects kidney proximal tubule cells from cadmium- and reactive oxygen species-induced apoptosis, J BIOL CHEM, 275(3), 2000, pp. 1887-1896
Citation: Ia. Hauser et Rb. Sterzel, Mycophenolate mofetil: therapeutic applications in kidney transplantation and immune-mediated renal disease, CURR OP NEP, 8(1), 1999, pp. 1-6
Authors:
Hauser, IA
Renders, L
Radeke, HH
Sterzel, RB
Goppelt-Struebe, M
Citation: Ia. Hauser et al., Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion, NEPH DIAL T, 14(1), 1999, pp. 58-63
Authors:
Neumayer, HH
Paradis, K
Korn, A
Jean, C
Fritsche, L
Budde, K
Winkler, M
Kliem, V
Pichlmayr, R
Hauser, IA
Burkhardt, K
Lison, AE
Barndt, I
Appel-Dingemanse, S
Citation: Hh. Neumayer et al., Entry-into-human study with the novel immunosuppressant SDZ RAD in stable renal transplant recipients, BR J CL PH, 48(5), 1999, pp. 694-703